Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation

A. Qi, I. C. Tuna, C. C. Gornick, T. P. Barragry, J. W. Blatchford, W. S. Ring, R. M. Bolman, M. J. Walker, D. G. Benditt

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a 1 hr period in 10 awake dogs before (group I studies) and during pharmacologic autonomic blockade (group 2 studies), and in a subset of these dogs (n = 5) after orthotopic cardiac transplantation (group 3 studies). In group 1 dogs, sinus cycle length (SCL) initially shortened after verapamil (postverapamil 379 ± 50 msec vs baseline of 494 ± 72 msec, p < .001) and subsequently gradually prolonged. In groups 2 and 3, transient SCL shortening was absent. SCL prolonged promptly after verapamil, and sinus arrest developed in two of 10 group 2 and two of five group 3 animals. Verapamil exerted a negative dromotropic effect on atrioventricular node conduction in all three experimental groups, as assessed by drug-induced changes in minimum cycle length with sustained 1:1 atrioventricular conduction and measurements of atrioventricular node effective and functional refractory period. However, compared with findings in group 1, this negative dromotropic effect occurred more rapidly and was markedly potentiated in groups 2 and 3. The time course of drug action was also affected by experimental conditions. For instance, peak effects of verapamil on atrioventricular node electrophysiologic properties occurred later in group 1 (30 to 60 min) than in group 2 or 3 (5 to 10 min). Verapamil plasma levels did not account for differences in drug effects in the three experimental groups. Thus, in the awake unsedated subject, both the magnitude and time course of parenteral verapamil's direct negative chronotropic effect on the sinus node and its negative dromotropic effect on the atrioventricular node are substantially modified by indirect effects mediated through neural mechanisms and alterations of circulating catecholamines. Potentially, both of these direct electrophysiologic effects of verapamil may be accentuated in clinical settings in which indirect moderating influences are diminished (e.g., concomitant treatment with sympatholytic drugs; cardiac transplantation).

Original languageEnglish (US)
Pages (from-to)888-893
Number of pages6
JournalCirculation
Volume75
Issue number4
StatePublished - 1987

Fingerprint

Heart Transplantation
Verapamil
Atrioventricular Node
Dogs
Catecholamines
Sympatholytics
Pharmaceutical Preparations
Sinoatrial Node
Intravenous Administration

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Qi, A., Tuna, I. C., Gornick, C. C., Barragry, T. P., Blatchford, J. W., Ring, W. S., ... Benditt, D. G. (1987). Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. Circulation, 75(4), 888-893.

Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. / Qi, A.; Tuna, I. C.; Gornick, C. C.; Barragry, T. P.; Blatchford, J. W.; Ring, W. S.; Bolman, R. M.; Walker, M. J.; Benditt, D. G.

In: Circulation, Vol. 75, No. 4, 1987, p. 888-893.

Research output: Contribution to journalArticle

Qi, A, Tuna, IC, Gornick, CC, Barragry, TP, Blatchford, JW, Ring, WS, Bolman, RM, Walker, MJ & Benditt, DG 1987, 'Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation', Circulation, vol. 75, no. 4, pp. 888-893.
Qi, A. ; Tuna, I. C. ; Gornick, C. C. ; Barragry, T. P. ; Blatchford, J. W. ; Ring, W. S. ; Bolman, R. M. ; Walker, M. J. ; Benditt, D. G. / Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. In: Circulation. 1987 ; Vol. 75, No. 4. pp. 888-893.
@article{eabe6f7c1cda436c8abdc8d29b4fd487,
title = "Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation",
abstract = "Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a 1 hr period in 10 awake dogs before (group I studies) and during pharmacologic autonomic blockade (group 2 studies), and in a subset of these dogs (n = 5) after orthotopic cardiac transplantation (group 3 studies). In group 1 dogs, sinus cycle length (SCL) initially shortened after verapamil (postverapamil 379 ± 50 msec vs baseline of 494 ± 72 msec, p < .001) and subsequently gradually prolonged. In groups 2 and 3, transient SCL shortening was absent. SCL prolonged promptly after verapamil, and sinus arrest developed in two of 10 group 2 and two of five group 3 animals. Verapamil exerted a negative dromotropic effect on atrioventricular node conduction in all three experimental groups, as assessed by drug-induced changes in minimum cycle length with sustained 1:1 atrioventricular conduction and measurements of atrioventricular node effective and functional refractory period. However, compared with findings in group 1, this negative dromotropic effect occurred more rapidly and was markedly potentiated in groups 2 and 3. The time course of drug action was also affected by experimental conditions. For instance, peak effects of verapamil on atrioventricular node electrophysiologic properties occurred later in group 1 (30 to 60 min) than in group 2 or 3 (5 to 10 min). Verapamil plasma levels did not account for differences in drug effects in the three experimental groups. Thus, in the awake unsedated subject, both the magnitude and time course of parenteral verapamil's direct negative chronotropic effect on the sinus node and its negative dromotropic effect on the atrioventricular node are substantially modified by indirect effects mediated through neural mechanisms and alterations of circulating catecholamines. Potentially, both of these direct electrophysiologic effects of verapamil may be accentuated in clinical settings in which indirect moderating influences are diminished (e.g., concomitant treatment with sympatholytic drugs; cardiac transplantation).",
author = "A. Qi and Tuna, {I. C.} and Gornick, {C. C.} and Barragry, {T. P.} and Blatchford, {J. W.} and Ring, {W. S.} and Bolman, {R. M.} and Walker, {M. J.} and Benditt, {D. G.}",
year = "1987",
language = "English (US)",
volume = "75",
pages = "888--893",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation

AU - Qi, A.

AU - Tuna, I. C.

AU - Gornick, C. C.

AU - Barragry, T. P.

AU - Blatchford, J. W.

AU - Ring, W. S.

AU - Bolman, R. M.

AU - Walker, M. J.

AU - Benditt, D. G.

PY - 1987

Y1 - 1987

N2 - Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a 1 hr period in 10 awake dogs before (group I studies) and during pharmacologic autonomic blockade (group 2 studies), and in a subset of these dogs (n = 5) after orthotopic cardiac transplantation (group 3 studies). In group 1 dogs, sinus cycle length (SCL) initially shortened after verapamil (postverapamil 379 ± 50 msec vs baseline of 494 ± 72 msec, p < .001) and subsequently gradually prolonged. In groups 2 and 3, transient SCL shortening was absent. SCL prolonged promptly after verapamil, and sinus arrest developed in two of 10 group 2 and two of five group 3 animals. Verapamil exerted a negative dromotropic effect on atrioventricular node conduction in all three experimental groups, as assessed by drug-induced changes in minimum cycle length with sustained 1:1 atrioventricular conduction and measurements of atrioventricular node effective and functional refractory period. However, compared with findings in group 1, this negative dromotropic effect occurred more rapidly and was markedly potentiated in groups 2 and 3. The time course of drug action was also affected by experimental conditions. For instance, peak effects of verapamil on atrioventricular node electrophysiologic properties occurred later in group 1 (30 to 60 min) than in group 2 or 3 (5 to 10 min). Verapamil plasma levels did not account for differences in drug effects in the three experimental groups. Thus, in the awake unsedated subject, both the magnitude and time course of parenteral verapamil's direct negative chronotropic effect on the sinus node and its negative dromotropic effect on the atrioventricular node are substantially modified by indirect effects mediated through neural mechanisms and alterations of circulating catecholamines. Potentially, both of these direct electrophysiologic effects of verapamil may be accentuated in clinical settings in which indirect moderating influences are diminished (e.g., concomitant treatment with sympatholytic drugs; cardiac transplantation).

AB - Cardiac electrophysiologic effects of verapamil in vivo are the result of both direct and indirect actions on the heart (the latter due to augmentation of sympathetic neural tone, diminution of parasympathetic neural tone, and increased circulating catecholamines). In this study we assessed the interaction of verapamil's direct and indirect actions on electrophysiologic properties of the heart in awake, previously instrumented, unsedated dogs. After administration of intravenous verapamil (0.2 mg/kg), electrophysiologic effects were assessed serially over a 1 hr period in 10 awake dogs before (group I studies) and during pharmacologic autonomic blockade (group 2 studies), and in a subset of these dogs (n = 5) after orthotopic cardiac transplantation (group 3 studies). In group 1 dogs, sinus cycle length (SCL) initially shortened after verapamil (postverapamil 379 ± 50 msec vs baseline of 494 ± 72 msec, p < .001) and subsequently gradually prolonged. In groups 2 and 3, transient SCL shortening was absent. SCL prolonged promptly after verapamil, and sinus arrest developed in two of 10 group 2 and two of five group 3 animals. Verapamil exerted a negative dromotropic effect on atrioventricular node conduction in all three experimental groups, as assessed by drug-induced changes in minimum cycle length with sustained 1:1 atrioventricular conduction and measurements of atrioventricular node effective and functional refractory period. However, compared with findings in group 1, this negative dromotropic effect occurred more rapidly and was markedly potentiated in groups 2 and 3. The time course of drug action was also affected by experimental conditions. For instance, peak effects of verapamil on atrioventricular node electrophysiologic properties occurred later in group 1 (30 to 60 min) than in group 2 or 3 (5 to 10 min). Verapamil plasma levels did not account for differences in drug effects in the three experimental groups. Thus, in the awake unsedated subject, both the magnitude and time course of parenteral verapamil's direct negative chronotropic effect on the sinus node and its negative dromotropic effect on the atrioventricular node are substantially modified by indirect effects mediated through neural mechanisms and alterations of circulating catecholamines. Potentially, both of these direct electrophysiologic effects of verapamil may be accentuated in clinical settings in which indirect moderating influences are diminished (e.g., concomitant treatment with sympatholytic drugs; cardiac transplantation).

UR - http://www.scopus.com/inward/record.url?scp=0023091138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023091138&partnerID=8YFLogxK

M3 - Article

VL - 75

SP - 888

EP - 893

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 4

ER -